AGP Picks
View all

The Asia Pacific Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Asia Pacific Examiner.

Press releases published on October 13, 2026

Oorja Bio Announces Initiation of ORBIT-IPF Phase 2 Clinical Trial Evaluating ORJ-001 for the Treatment of Idiopathic Pulmonary Fibrosis
Biodexa announces another Serenta milestone with 100 patients enrolled in its registrational Phase 3 trial in FAP
Skillful Craftsman to Acquire Controlling Interest in Singapore-Based URAY
ITB Asia 2026 Highlights the Growing Role of Digital Connectivity in Travel
Dim Sum as a Popular Dining Choice: Live Webinar for Food Business Owners Hosted by ANKO on Oct. 22
TaiMed Biologics to Present Oral and Poster Presentations on TMB-365 and TMB-365/TMB-380 Combination Therapy at IDWeek 2026
Yorbeau Creates a Base Metal Company
Yorbeau Crée Une Société Dédiée Aux Métaux De Base
JADENS JD-410WF: The First Multi-Device Thermal Label Printer with 2.4 GHz and 5 GHz Dual-Band Wi-Fi
Tenvie Therapeutics Announces First Subject Dosed in Phase 1 Trial of TNV313, Expanding Its Fully CNS-Penetrant NLRP3 Franchise
Reflect Scientific Introduces PF-90 Blast Plate Freezer, Combining Two Freezing Technologies for Biopharmaceutical and Cell Therapy Applications
Immutep Regains Compliance with Nasdaq Minimum Bid Price Requirement
Diginex Shareholders Approve Transformative Resulticks Combination, to Create a Global AI-Powered Enterprise Intelligence Platform
Genius Group Launches Genius High as a scalable model for AI-Powered Future Schools.
SPARC AI to Sponsor the Ukrainian Defense Tech Pavilion Reception at AUSA 2026
Maxus Mining Completes Multi-Project VTEM Survey Across British Columbia Critical Minerals Portfolio
Zenta Group Company Limited Announces Strategic Re Alignment of Business Focus to AI and Data Solutions
Prelude Announces Clinical Trial Collaboration and Supply Agreement with Lilly to Evaluate KAT6A Selective Degrader PRT13722 in Combination with Verzenio® and Inluriyo® in Patients with HR+/HER2- Breast Cancer
ZoomRx Launches Marketing Asset Testing (MAT) on Sagan Agents, Bringing Continuous, Channel-Specific Asset Testing to Pharma Brand Teams
Triveni Bio Doses First Patient in Global Phase 2 Proof-of-Concept Study of TRIV-573 in Atopic Dermatitis and Provides I&I Pipeline Update

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Asia Pacific Examiner

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.